Related Experiment Videos
Low dose bleomycin and methotrexate in cervical cancer
Cancer
|February 1, 1976
Summary
This study combined Bleomycin and Methotrexate chemotherapy for advanced cervical cancer. Results showed significant tumor reduction in 60% of patients, suggesting improved treatment outcomes for metastatic cervical cancer.
Area of Science:
- Oncology
- Medical Chemotherapy
Background:
- Recurrent and disseminated cervical cancer presents a significant clinical challenge.
- Limited effective treatment options exist for advanced stages of cervical cancer.